Apr 10, 2025
Host Dr. Davide Soldato and guests Dr. Jessica Burris discuss the article "Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons Accredited Cancer Programs" and how persistent smoking following cancer diagnosis causes adverse outcomes while smoking cessation can improve survival.
TRANSCRIPT
The guest on this
podcast episode has no disclosures to
declare.
Dr. Davide
Soldato
Hello and welcome to
JCO After Hours, the podcast where we sit down
with authors from some of the latest articles published in the
Journal of Clinical Oncology. I am your host, Dr.
Davide Soldato, medical oncologist at Ospedale San Martino in
Genoa, Italy.
Today we are joined by JCO author Dr. Jessica Burris. Dr. Burris is an Associate professor of Psychology at the University of Kentucky and co leader of the Cancer Prevention and Control Research Program at the Markey Cancer Center. Her research focuses on smoking cessation among cancer survivors, health disparities, and behavioral interventions to promote health equity. She also leads the BIRDS Lab, which explores the intersection of smoking, social determinants of health, and cancer survivorship. Today I will be discussing with Dr. Burris on the article titled Longitudinal Results from the Nationwide Just Ask Initiative to Promote Routine Smoking Assessment in American College of Surgeons Accredited Cancer Program. So, thank you for Speaking with us, Dr. Burris.
Dr. Jessica
Burris
Thank you for inviting
me.
Dr. Davide
Soldato
So today we'll be
discussing an important study on the implementation of smoking
assessment in cancer care and specifically through the Just Ask
Initiative. So, we know that tobacco use is a critical factor in
cancer treatment outcomes in general, and yet integrating
systematic smoking assessment into oncology care has faced various
challenges. So, Dr. Burris, to start off our interview, I would
like to ask you to briefly introduce the Just Ask Initiative for
those of our readers and listeners who may not be familiar with it.
So, a little bit about the primary goals and why do you think that
routine smoking assessment is such an important aspect of cancer
care and why the Just Ask Initiative focuses on this specific
issue?
Dr. Jessica
Burris
Sure. So, as you
mentioned before, smoking is a really critical factor in terms of
cancer care and cancer outcomes. It impacts a lot of things, from
complications after surgery up into cancer mortality, but it also
impacts patient's quality of life. Their pain may be more severe,
they're more tired, their distress levels are higher. So, there's
just a lot of different reasons why we need to understand and
address smoking in the context of cancer care. But like you said
too, there's a lot of barriers as well. But in order to effectively
treat nicotine dependence and tobacco use, we really need to know
who is currently smoking. And so that was really the driver for
Just Ask, wanting to make sure that we are asking every person with
cancer at their diagnosis and as they go through treatment, what
their smoking history is, if they are currently smoking, which we
usually consider to be any smoking or other tobacco use in the past
30 days, so that once we can identify that person, then we know who
we need to help.
Dr. Davide
Soldato
Thank you very much.
That was very clear. And in terms of methodology, Just Ask was
really a quality improvement type of initiative that involved the
programs that were contacted and approached to participate in this
type of initiative. And the methodology is pretty standard for this
type of implementation science, which is the Plan Do Study Act
methodology. So just a little bit of background on this type of
methodology and why do you think it might be so successful when
implementing these types of changes at the structural level and
when we are implementing these types of programs.
Dr. Jessica
Burris
Right. So, the
American College of Surgeons requires all the accredited cancer
programs, both Commission on Cancer and the NAPBC or the ones that
focus on breast cancer, to do at least one quality improvement
project annually. And most of the programs do use the
evidence-based Plan Do Study Act approach. I think it's a great
one. It has a lot of evidence behind it, but it also is very
practical or pragmatic. So, you're using data from your local
healthcare system or clinic or program to inform what it is that
you do. And then you're constantly pulling data out to see how well
you're addressing the clinical practice change that you're hoping
to achieve. And so, data is going in and coming out and you're
using that to inform exactly what it is that you're doing over
time. So, it's an iterative approach to practice change and again,
one that has proven successful time and time again. And so that's
the program that these programs and Just Ask used in order to
increase the frequency by which they ask patients about
smoking.
Dr. Davide
Soldato
So as you were saying,
the main objective of the initiative was really to understand if we
are asking patients diagnosed with cancer and survivors if they are
smoking. And how can we better report this information inside of
the medical chart of the patient. So, what was the primary endpoint
or the objective that you had for this type of intervention? And
can you give us a little bit of results? So, what did you find the
implementation of this quality improvement? How did it change the
percentages of patients that were asked about smoking habits? And a
little bit, what is your opinion on the results that you obtain in
the study?
Dr. Jessica
Burris
Sure. So, the goal was
simple and that was to have an ask rate that was at least 90%. The
way that we defined an ask rate is among all newly diagnosed cancer
patients, how many were asked about their smoking history and their
current status at that initial visit? And so, we wanted all of the
participating programs who opted in to Just Ask in 2022 to achieve
that 90% ask rate by the end of this one-year quality improvement
project. And again, using the Plan Do Study Act approach, it was a
very pragmatic study in some ways. So, what we did was we provided
an intervention change package that we made available online. And
programs could access that whenever they needed to and pull-down
educational resources, patient facing materials, practical tools
for changing the EHR or pulling data out of the EHR, any of those
number of things. And then we also hosted webinars over the course
of the year. And those webinars were great because half the time
they were in response to questions that programs were asking as
they went through the Just Ask QI project. And the other half of
time we were really just reminding programs of the rationale and
the reason for making sure that they're asking. And then of course,
letting them know that they don't have to stop there, they should
be advising patients to quit and assisting them with cessation.
Even though that wasn't the goal of Just Ask, the goal again of
Just Ask was getting that 90% rate. And so, we had over 750
programs who opted in to Just Ask and did this QI study with us,
and it was successful. So, we met the goal, or rather the programs
met the goal of that 90% ask rate. And that was maintained over
time. And that was just fantastic. So again, we know that the end
goal is really to assist patients with quitting, but we can't do
that unless we know who to help. And so, you have to ask first. And
again, they were able to do that.
Dr. Davide
Soldato
So thank you very
much. The quality improvement program was absolutely successful.
And to go a little bit in the numbers, by the end of the one-year
implementation of the program, you report a 98% rate of asking
patients who first approached the centers or over time if they were
or not smokers. So, you said before that you targeted a 90% ask
rate in terms of smoking habits. But when looking at the data, I
noticed that you already had in the baseline survey where you asked
the programs about what were the practice before the implementation
of the Just Ask initiative, already something that was quite close
to the 90%. And yet, despite starting from such a good point, which
was basically your endpoint, you still observed a major change over
the years of the implementation. So, I wanted to just underline a
little bit what is the value of this type of programs. And still
starting from such a very high standard still, we managed to
further improve. And as you were saying, this is pivotal and I
think it's fundamental to really understand and see who are the
patients that we need to refer and then to help in the smoking
cessation. So, I just wanted a little bit of a comment on these
very important results, despite already starting from a very good
background from the centers.
Dr. Jessica
Burris
Yeah, I'm glad that
you brought up the baseline. So, I think one thing that's important
about this study is that we looked at our ask rate or the asking as
a clinical practice in two different ways. So, the 98% that you
referred to that we found at the final survey is based on a
response to a question on the frequency of asking. So, it's a
Likert type question. And essentially what we did was we combined
programs that reported usually asking or almost always asking into
one, and that's where we arrived at the 98%. And at baseline it was
92%. What's interesting though is that we also asked them to report
the specific number of patients who were seen in their cancer
program during the prior six months and the number of patients who
were asked about smoking in the prior six months. And with that we
could get a proportion. And in every case, the self-report Likert
question had a higher outcome than the raw data based on the data
that was pulled from the EHR. And so, we saw this increase
significantly over time, both in the self-report Likert question,
but also in the EHR based data. And so, it was a win in two ways.
What I think is really interesting though is that at baseline, even
though 92% of programs said that they regularly ask about their
patient smoking status, 16% of programs could not provide data that
would allow calculation of an ask rate. So, they were reporting
that they were able to do so but then could not actually do so. So,
I think what that means essentially is that there's a disconnect
between what programs are doing regularly or they believe that
they're doing regularly and what their data actually shows. And it
could be an issue with the quality of the data that's going into
the EHR, or it could be an issue with pulling the data out of the
EHR. And so one of the things that we saw that I think is a second
indicator of success of Just Ask is that the quality of the data
that programs were inputting into the EHR related to their patients
smoking history and smoking status did improve over time, which
meant that by the end it really was the case that the vast majority
of programs were asking. And not only that, but they were also
documenting it in a way to where it could inform patient care. Does
that make sense?
Dr. Davide
Soldato
Absolutely. And I
think that that explanation really is truly important because I
think that it also connects a little bit to how the initiative was
able also to change things at the structural level, to be sure that
there was the best possible way of asking, but also of having that
information readily available inside of the EHR. This also connects
a little bit to my next question, which was a little bit about
organizational structure and also implementation barriers, which
you report also as a self-reported information by the specific
programs. So, there was a little bit of implementation barriers
that was reported by the programs and this was not a specific
endpoint of the Just Ask initiative, but you kind of mentioned it a
little bit. The difficulties in pulling data from the EHR in
understanding whether the information was collected and how it was
collected. This might be one of the implementation barrier when we
are looking at initiatives like Just Ask. So, I just wanted a
little bit of your opinion if you think that these implementational
barriers are more on the organizational side or on the provider
side. And how can we use these quality improvement programs to
really tackle this type of barriers to improve overall the reach
and the importance of our action regarding smoking
cessation.
Dr. Jessica
Burris
The devils in the
details, right? So I think it's a “both and” situation and not
either or I think for providers, for individual providers,
oncologists, nurses, supportive care providers, the issue of
feeling like they're not fully trained in tobacco use assessment
and treatment, and also feeling because of a lack of training that
they don't feel confident or competent or even comfortable having
conversations with their patients about their smoking history or
being in the position to where they can really help someone who
wants to quit in choosing the best path and way forward to do that
that really matters. And so organizational readiness, these
programs that participated were pretty high even at baseline in
terms of the organizational readiness. They understood that it's a
problem and they wanted to do something about it. And they were
really eager and chomping at the bit to do so. But that has to
trickle down to individual providers. And so, I think one of the
implementation strategies that was used was staff training and
provider education. And a lot of the participating programs chose
that strategy. And I think as staff and providers are trained in
how to ask and how to do so in a way that is nonjudgmental and that
doesn't lean into things like stigma or blame or making patients
feel guilty that perhaps their behavior led to their cancer, but
really just understanding tobacco history and understanding
nicotine dependence and the best strategies that we have to address
those things that helped and that made a difference but it also is
things at the system level, like having good EHR data, being able
to pull those data out at a regular interval every three months or
every four months, or even every six months to make sure that
you're tracking smoking and also quitting over time. Both of those
things need to happen. And I think those were things that we saw
change as a result of Just Ask participation.
Dr. Davide
Soldato
Relating to this,
provider readiness also to counsel patients on how to stop smoking
or what is the best strategy. Despite, as you said in the very
beginning, this was not the objective of Just Ask because you just
wanted to improve the rate of smoking assessment and the quality of
reporting of smoking assessment. You still observed higher rates of
patients and survivors that were actually referred to some kind of
intervention for smoking cessation. So, I was just wondering, why
do you think that even though that was not required, you still
observe this type of improvement? Like, is it just inherent to the
fact that we are improving and we are placing more interest and
more attention on the fact that patients should quit smoking, or do
you think that it relates to something else
completely?
Dr. Jessica
Burris
I think there's
probably multiple things going on. One is once you're fully aware
of the fact of the impact of smoking after a cancer diagnosis,
you're going to be compelled to do something, I think. And so just
the simple fact of knowing now that the patient sitting in front of
you has smoked in the past week or two, they may be under a lot of
stress because they're coping with cancer and they're coping with
the side effects of their treatment. They may even have increased
their smoking since their cancer diagnosis. And now you have this
information. I think people who are providing cancer care, they
want to improve the health and the life of the person sitting in
front of them. And if they understand that smoking is a detriment
or a hurdle to their doing so, then they're also more inclined to
try and help that person quit smoking. And so, I think the asking
and the documenting likely led to an increase in assistance and
referrals to tobacco treatment specialists or to a state quit line,
which was also common, simply because that's part of providing
quality care. I think also there's been a greater emphasis
nationally, in part led by the National Cancer Institute and a
cancer moonshot initiative that it led, they're really focused on
getting more treatment to more patients with smoking and increasing
the reach and the effectiveness of the treatments that we provide.
And so, I think there has been a shift in oncology care broadly to
put more attention on smoking and smoking cessation as part of
standard cancer care. And so, I think this kind of shift in the
field also informed things as well as, again, thinking about the
patient and the individual who's in the room and wanting to do
something about the problem that you've just
identified.
Dr. Davide
Soldato
And one thing that I
believe is truly exceptional about the Just Ask initiative is
really also the diversity of the type of programs that you
involved. Like, you went from community centers to more academic
centers. And really, I did not have the impression reading the
manuscript that there was any difference in the way this type of
quality improvement initiative can really benefit all these
programs and all these centers. So, I was just wanting to have your
opinion or comment on how do you think this type of initiative
could be transferable across the country and across different
settings and different types of cancer care?
Dr. Jessica
Burris
Yeah, I'm really glad
that you brought that up, because I think most of the clinical
trials that are done in this area are done at academic medical
centers, which are admittedly kind of resource rich places to
receive cancer care. And so, what works in academic medical center
may not work in a small rural practice in the middle of Kansas, for
example, or in Mississippi. And it may not work in other
community-based practices, even if they're larger and set in an
urban setting. And so, one of the things that frankly I loved about
Just Ask is that it was very heterogeneous in terms of the sites
and the participating groups. And so not only was it national and
by far the largest initiative in this area, again with over 750
different programs, but the programs were diverse. So, we had large
community-based programs, integrated networks, smaller community
programs. And then the academic centers were actually the smallest.
Only like 10 or 12 out of the 750 plus were academic. And so, it
was very different than what is the norm in this research area and
in this area generally in terms of clinical practice. And we were
able to show that the type of program that participated had no
bearing on their success. And so, when we think about initiatives
that work and interventions that work, we also really have to think
about what is scalable and what could be disseminated across
different practices. And this is one of those things that can. It
worked and it worked across different swaths of group, which was
great.
Dr. Davide
Soldato
Absolutely. And just
one last comment about the intervention, and it's also a point that
you raised in the manuscript. This initiative, like many others
also at the national levels that have been reported previously,
they rarely had really the participation or the perspective of the
patients embodied inside of them. So, I was wondering, how do you
see the field moving forward. Like you envision something that
would implement sort of a co-creation with patients or cancer
survivors in order to really create something that is more
appealing and takes more into consideration what is the patient
perspectives when we are approaching something like smoking
cessation, which as you were mentioning before, it can have a lot
of stigma or already some negative feelings by the patients and
feelings of guilt regarding the fact that they smoked and that
might have caused that cancer. So just a little bit of your opinion
as to how you see the implementation science in smoking cessation
moving forward while integrating also the patient
perspectives.
Dr. Jessica
Burris
Yeah, that's a great
question. So, this is something that I've thought about a lot in my
lab and at Market Cancer center, which I'll use as an example. But
oftentimes what we see is that even when tobacco treatment is
offered as part of standard cancer care, even when we try to remove
barriers like the financial cost of treatment at Markey, we embed
it within our psych oncology program. And so, all of those services
are offered for free. The rate at which patients say, yes, they
want to engage in treatment is much, much lower than what we would
want. And so that means two things. One, we need to offer help
repeatedly to patients and understand that their willingness to
quit and their willingness to accept treatment likely would change
over time. And so, we need to keep coming back to people. It's not
a one and done situation. But then also we need to understand what
the barriers are from a patient's perspective. So why are they
saying no? That they're either not ready or that they don't want
treatment. They want to, quote, unquote, go it alone. And
oftentimes what we hear is that patients want to be able to do this
by themselves. They want to feel like, I quit smoking and I did it
all by myself. And this is this huge thing that I've overcome. Not
too different from the perspective that a lot of patients have
about fighting cancer. They want to fight this addiction, this
dependence that they've had oftentimes for multiple decades. And
so, I think one thing that might be beneficial is to think about
having peer led tobacco treatment. So have a patient who was able
to quit successfully and have them provide counseling alongside a
trained provider so that patients see someone like them who's went
through it in the context of cancer care and who was able to
overcome and to fight and win against tobacco, essentially. I think
the other thing is trying to make sure that when we're asking about
smoking and when we're offering treatment that we are not
accidentally harming patients by bringing up feelings of stigma or
guilt or shame. And I think one way to make sure we don't do that
is to really lean on clinicians who are trained in addressing
social determinants of health and other supportive care. So, our
social workers, I think would be great. They're oftentimes embedded
within oncology care. They are surely able to be trained as tobacco
treatment specialists. They're already working with patients;
they're addressing other barriers to care. They're sensitive in how
they ask questions oftentimes. And so, they're really an ideal
partner for this work. And we have found in a lot of settings that
social workers are great in terms of being tobacco treatment
specialists, including what we saw in Just Ask.
Dr. Davide
Soldato
Thank you very much.
That was really very, very interesting. And so, last question,
moving forward, we improved the rate of asking patients. We are
able to document this addiction more clearly in the EHR. So how do
you see the field moving forward? In the manuscript, you speak a
little bit about the Beyond Ask initiative. So just a little bit of
a background about what is this initiative, what you are planning
to do, and what do you think would be the best way to really act on
this information that we are starting to collect in a better way
and more frequently.
Dr. Jessica
Burris
Yeah. So Beyond Ask
really took everything that we did in Just Ask and amplified it. So
instead of focusing on asking, we really said to make a difference
and to improve cancer outcomes, ultimately patients need to be able
to quit smoking. It's not enough that we know who is smoking, but
that we help that individual or those groups of people quit. And so
Beyond Ask had the goal to increase cessation assistance. So,
either prescribing medication to help with smoking cessation,
referring to a quit line, or another evidence-based program, or
personally providing cessation counseling on site at that cancer
program and to try and improve again within assistance. It was
another one-year study, but we increased the frequency of surveys.
I think we ended up with five total surveys. So, we were capturing
two to three months at a time instead of a six-month period. And
the data that we were capturing was very similar to what we did in
Just Ask. And I can say we're still doing the data analysis, but it
was another major success. So, with Beyond Ask, we had about 350
participating programs, many of whom not all, but many did
participate in Just Ask. So, I think Just Ask kind of energized
people around addressing the issue of smoking in their patient
population. And again, they were really chomping at the bit to do
more. And so, we offered Beyond Ask just after Just Ask. So Just
Ask was 2022. Beyond ask was 2023. It ended in the spring of 2024.
And again, another success.
Dr. Davide
Soldato
Thank you very much.
So, we are eager to see the results of this study. So that leads us
to the end of this interview. So, thank you again, Dr. Burris for
joining us today and speaking about your work.
Dr. Jessica
Burris
Thank
you.
Dr. Davide
Soldato
So we appreciate you
sharing more on the JCO article titled Longitudinal Results from the Nationwide Just Ask
Initiative to Promote Routine Smoking Assessment in American
College of Surgeons Accredited Cancer Program. If you enjoy our
show, please leave us a rating and a review and be sure to come
back for another episode. You can find all ASCO shows at
asco.org/podcast.
The purpose of
this podcast is to educate and to inform. This is not a substitute
for professional medical care and is not intended for use in the
diagnosis or treatment of individual conditions. Guests on this
podcast express their own opinions, experience and conclusions.
Guest statements on the podcast do not express the opinions of
ASCO. The mention of any product, service, organization, activity
or therapy should not be construed as an ASCO
endorsement.